Walmart says it is expanding benefits for employees by covering certain medications at no cost, including Novo Nordisk’s Ozempic and Eli Lilly’s Mounjaro, alongside other treatments such as some inhalers and insulin. CNBC reports that the coverage is provided for employees with Type 2 diabetes, with access tied to a prior authorization process.
The company is also adding more than 250 covered prescriptions overall, according to the outlets, and it pairs the drug coverage with additional benefits such as paid NICU leave, therapy sessions, and family-building support. Inc. and Quartz also note that Walmart is limiting the cost increase for its premium plan, stating that the rise is capped at $1.50 per pay period.
Across the sources, the shared emphasis is on Walmart’s broader shift toward covering a wider range of medications for employees while keeping employee premium increases relatively small. The reports also place the move in the context of wider employer benefit changes affecting prescription coverage.
